Schivo has acquired Mecaplast Swiss SA for an undisclosed amount. This corporate acquisition sees Schivo taking ownership of Mecaplast Swiss, a leading expert in plastic injection molding. Since 1971, Mecaplast Swiss has established itself as a reference Contract Manufacturing Organization (CMO) for the Life Sciences and MedTech sectors, complementing its historical presence in industry and luxury markets. The company operates in both conventional and fully controlled ISO 7 environments.
Mecaplast Swiss is known for its "360° injection molding" approach, which offers completely integrated services designed to streamline development and accelerate industrialization. These services encompass design optimization, prototyping, industrialization, tool and mold making, plastic injection, assembly, quality assurance, finishing, cleaning, packaging, storage, and distribution. Mecaplast Swiss's commitment to quality and its one-stop shop concept have attracted numerous start-ups and established international companies.
This acquisition is strategically significant for Schivo, substantially enhancing its capabilities and market presence in high-precision manufacturing, particularly within the critical Life Sciences and MedTech industries. The integration of Mecaplast Swiss’s comprehensive service offering, covering the entire product lifecycle from engineering to logistics, is expected to create strong synergies. These combined strengths will allow the unified entity to provide a more complete and efficient value chain to its clients.
Looking forward, the combined operations are positioned to offer expanded technical expertise, greater manufacturing capacity, and a broader service portfolio to global partners. This integration is anticipated to drive innovation and reinforce the combined entity's leadership in providing specialized manufacturing solutions for regulated sectors, ultimately benefiting clients seeking integrated product development and supply chain management.